{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:05:25Z","timestamp":1789329925105,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2024GXNSFAA010230"],"award-info":[{"award-number":["2024GXNSFAA010230"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.acra.2026.08.110","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:25:50Z","timestamp":1789212350000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical, CT Radiomic, and Pathomic Models for FOS Immunohistochemical Status Defined by the Training-Cohort Median in Ovarian Cancer"],"prefix":"10.1016","author":[{"given":"Lan-hui","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-xin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-8532","authenticated-orcid":false,"given":"Liling","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2026.08.110_bib1","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2147\/CMAR.S538281","article-title":"Metabolic reprogramming shapes the progression and therapeutic landscape of ovarian cancer","volume":"17","author":"Liu","year":"2025","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.acra.2026.08.110_bib2","article-title":"The pharmacological mechanism of chinese herbs effective in treating advanced ovarian cancer: integrated meta-analysis and network pharmacology analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"18","key":"10.1016\/j.acra.2026.08.110_bib3","first-page":"2191","article-title":"Burden of female breast and five gynecological cancers in China and worldwide","volume":"137","author":"Tan","year":"2024","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib4","article-title":"Metabolic reprogramming and prognostic insights in molecular landscapes driven by glycolysis in ovarian cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.acra.2026.08.110_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70681","article-title":"Navigating metabolic challenges in ovarian cancer: insights and innovations in drug repurposing","volume":"14","author":"Mikhael","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.acra.2026.08.110_bib6","article-title":"Crosstalk between stromal, immune, and ovarian cancer cells in lipid-rich tumor microenvironment exhibits proliferative features","volume":"16","author":"Ma","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.acra.2026.08.110_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2025.106816","article-title":"Research progress of lipid metabolism reprogramming and related drug therapy in ovarian cancer","volume":"253","author":"Li","year":"2025","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib8","article-title":"Development of a radiomic model to predict CEACAM1 expression and prognosis in ovarian cancer","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1186\/s12967-025-07229-0","article-title":"CT radiomic stratification signature to optimize clinical decisions for ovarian cancer patients receiving neoadjuvant chemotherapy and the underlying biological basis: a multicenter retrospective study","volume":"23","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"issue":"13","key":"10.1016\/j.acra.2026.08.110_bib10","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.3390\/jcm11133888","article-title":"Identification of new molecular biomarkers in ovarian cancer using the gene expression profile","volume":"11","author":"Olbromski","year":"2022","journal-title":"J Clin Med"},{"issue":"832","key":"10.1016\/j.acra.2026.08.110_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adt8706","article-title":"Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer","volume":"18","author":"Duffield","year":"2026","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.acra.2026.08.110_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2025.106952","article-title":"Elucidating the biological function of computed tomography (CT)-based radiomics biomarkers in serous ovarian cancer","volume":"86","author":"Kishi","year":"2025","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13048-024-01456-7","article-title":"Predicting CD27 expression and clinical prognosis in serous ovarian cancer using CT-based radiomics","volume":"17","author":"Zhang","year":"2024","journal-title":"J Ovarian Res"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-022-01089-8","article-title":"CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer","volume":"16","author":"Wan","year":"2023","journal-title":"J Ovarian Res"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13048-023-01248-5","article-title":"CT radiomics prediction of CXCL9 expression and survival in ovarian cancer","volume":"16","author":"Gu","year":"2023","journal-title":"J Ovarian Res"},{"issue":"12","key":"10.1016\/j.acra.2026.08.110_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32910","article-title":"CT-based radiomics predicts CD38 expression and indirectly reflects clinical prognosis in epithelial ovarian cancer","volume":"10","author":"Yao","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.acra.2026.08.110_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/CM9.0000000000003823","article-title":"Development of the model for predicting the efficacy of bevacizumab and prognosis in ovarian cancer using deep learning-based pathomics signatures","volume":"139","author":"Yin","year":"2026","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.acra.2026.08.110_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s12539-025-00809-0","article-title":"HRD-informed digital histology model for predicting platinum chemo-response and prognosis in high-grade serous ovarian cancer","author":"Yang","year":"2026","journal-title":"Interdiscip Sci"},{"issue":"22","key":"10.1016\/j.acra.2026.08.110_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70958","article-title":"Development of a PANoptosis-related pathomics prognostic model in ovarian cancer: a multi-omics study","volume":"29","author":"Zhang","year":"2025","journal-title":"J Cell Mol Med"},{"issue":"19","key":"10.1016\/j.acra.2026.08.110_bib20","doi-asserted-by":"crossref","first-page":"11326","DOI":"10.3390\/ijms231911326","article-title":"Deep-learning to predict BRCA mutation and survival from digital H&E slides of epithelial ovarian cancer","volume":"23","author":"Nero","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.acra.2026.08.110_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","article-title":"Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer","volume":"3","author":"Vanguri","year":"2022","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib22","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2589-7500(21)00215-6","article-title":"Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study","volume":"4","author":"Feng","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"11","key":"10.1016\/j.acra.2026.08.110_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7374","article-title":"A clinical-radiomic-pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection","volume":"13","author":"Xie","year":"2024","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib24","article-title":"Digital pathology and multimodal learning on oncology data","volume":"1","author":"Waqas","year":"2024","journal-title":"BJR Artif Intell"},{"issue":"3","key":"10.1016\/j.acra.2026.08.110_bib25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1148\/radiol.2021202553","article-title":"The biological meaning of radiomic features","volume":"298","author":"Tomaszewski","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib26","first-page":"51","article-title":"Deep texture analysis\u2014enhancing CT radiomics features for prediction of head and neck cancer treatment outcomes: a machine learning approach","volume":"4","author":"Safakish","year":"2024","journal-title":"Radiat (Basel)"},{"issue":"11","key":"10.1016\/j.acra.2026.08.110_bib27","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1093\/neuonc\/noaf090","article-title":"AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: analysis of 124 histologically assessed lesions","volume":"27","author":"Ressa","year":"2025","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.acra.2026.08.110_bib28","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/cancers14071646","article-title":"Identification of CT imaging phenotypes of colorectal liver metastases from radiomics signatures-towards assessment of interlesional tumor heterogeneity","volume":"14","author":"Tharmaseelan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.acra.2026.08.110_bib29","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.3390\/cancers15123074","article-title":"Radiogenomics analysis linking multiparametric MRI and transcriptomics in prostate cancer","volume":"15","author":"Dinis Fernandes","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.acra.2026.08.110_bib30","article-title":"Multi-size deep learning based preoperative computed tomography signature for prognosis prediction of colorectal cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.acra.2026.08.110_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115609","article-title":"The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients","volume":"226","author":"Italiano","year":"2025","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib32","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41467-020-17678-4","article-title":"A deep learning model to predict RNA-seq expression of tumours from whole slide images","volume":"11","author":"Schmauch","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.acra.2026.08.110_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011346","article-title":"Artificial intelligence-based digital pathology using H&E-stained whole slide images in immuno-oncology: from immune biomarker detection to immunotherapy response prediction","volume":"13","author":"Zhang","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13046-025-03370-2","article-title":"C-FOS promotes the formation of neutrophil extracellular traps and the recruitment of neutrophils in lung metastasis of triple-negative breast cancer","volume":"44","author":"Yan","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.acra.2026.08.110_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6784138","article-title":"Identification of FOS as a candidate risk gene for liver cancer by integrated bioinformatic analysis","volume":"2020","author":"Hu","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.acra.2026.08.110_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1708692","article-title":"Radiomics reveals the biological basis for non-small cell lung cancer prognostic stratification by reflecting tumor immune microenvironment heterogeneity","volume":"16","author":"Huang","year":"2025","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40364-023-00480-x","article-title":"Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy","volume":"11","author":"Cui","year":"2023","journal-title":"Biomark Res"},{"issue":"3","key":"10.1016\/j.acra.2026.08.110_bib38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00259-023-06468-x","article-title":"Exploring the association of glioma tumor residuals from incongruent [18F]FET PET\/MR imaging with tumor proliferation using a multiparametric MRI radiomics nomogram","volume":"51","author":"Li","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.acra.2026.08.110_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008927","article-title":"Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer","volume":"12","author":"Han","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13058-022-01516-0","article-title":"Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment","volume":"24","author":"Wang","year":"2022","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.acra.2026.08.110_bib41","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.crad.2022.01.038","article-title":"Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer","volume":"77","author":"Hong","year":"2022","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13048-021-00941-7","article-title":"MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols","volume":"15","author":"Wang","year":"2022","journal-title":"J Ovarian Res"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12967-024-05393-3","article-title":"CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment","volume":"22","author":"Wang","year":"2024","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib44","first-page":"77","article-title":"Radiomics and radiogenomics: extracting more information from medical images for the diagnosis and prognostic prediction of ovarian cancer","volume":"11","author":"Zeng","year":"2024","journal-title":"Mil Med Res"},{"issue":"3","key":"10.1016\/j.acra.2026.08.110_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jclinepi.2014.06.018","article-title":"A new framework to enhance the interpretation of external validation studies of clinical prediction models","volume":"68","author":"Debray","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: what, why, how, when and where?","volume":"14","author":"Ramspek","year":"2021","journal-title":"Clin Kidney J"},{"issue":"8","key":"10.1016\/j.acra.2026.08.110_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007858","article-title":"External validations of cardiovascular clinical prediction models: a large-scale review of the literature","volume":"14","author":"Wessler","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.acra.2026.08.110_bib48","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/jamia\/ocx030","article-title":"Calibration drift in regression and machine learning models for acute kidney injury","volume":"24","author":"Davis","year":"2017","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.acra.2026.08.110_bib49","article-title":"Evaluation of clinical prediction models (part 2): how to undertake an external validation study","volume":"384","author":"Riley","year":"2024","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.acra.2026.08.110_bib50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12916-023-02779-w","article-title":"There is no such thing as a validated prediction model","volume":"21","author":"Van Calster","year":"2023","journal-title":"BMC Med"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226007282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226007282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T19:58:08Z","timestamp":1789329488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226007282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S1076633226007282"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.08.110","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, CT Radiomic, and Pathomic Models for FOS Immunohistochemical Status Defined by the Training-Cohort Median in Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.08.110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}